Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD
Pilot Study of MiDialisis App Usage (Estudio Piloto de Uso de MiDiálisis App)
Aida Frías González
55 participants
Jul 27, 2025
INTERVENTIONAL
Conditions
Summary
The main goal of this study is to assess whether a mobile phone app called MiDiálisis is practical, easy to use, and well-accepted. The app was developed by the Technical University of Madrid (UPM) and is designed to bring together the clinical data of people with chronic kidney disease who are on peritoneal dialysis. This way, both patients and doctors can access the information at any time.
Eligibility
Inclusion Criteria5
- Patients over 18 years of age.
- Patients with chronic kidney disease who have been on PD for at least 3 months in the same hospital.
- Patients with a stable clinical condition during the 3 months prior to entering the study, defined as no unscheduled hospitalizations or major cardiovascular events (myocardial infarction or stroke) during that period.
- Availability of a smartphone or tablet and internet access for the patient/caregiver.
- Patients who understand the nature of the study and sign the informed consent form.
Exclusion Criteria5
- Patients with limitations for multifrequency body composition measurement (pacemaker or implantable cardioverter defibrillator wearers, and pregnant women).
- Patients who do not routinely use a smartphone or are unfamiliar with the use of mobile applications.
- Patients who are scheduled for a living kidney transplant in the next 6 months.
- Patients with a life expectancy of less than 6 months.
- Patients in a peritoneal ultrafiltration program due to cardiorenal syndrome.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
During Phase 2, patients will use the smart band continuously throughout the day.
During Phase 2, patients will weigh themselves daily using the scale.
Patients will enter daily blood pressure data and information related to their peritoneal dialysis therapy.
Patients will download and begin using the application.
Patients will connect the digital scale to the application via Bluetooth.
Patients will connect the smartband to the application via Bluetooth.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07326085